Kidney Cancer Archives - Renal and Urology News

A patient with cancer receives palliative care.

Sex Inequalities Persist in Cancer Clinical Trials

By

October 7, 2021

Men nearly always outnumbered women, regardless of trial phase, cancer type, time period, or cancer incidence in the female population.

Kidney Cancer

Preoperative Blood Glucose Level Linked to Length of Stay After Nephrectomy for Renal Cell Carcinoma

By

Vicki Moore, PhD

September 22, 2021

Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.

Kidney Cancer

First-Line Advanced RCC Combo Tx Improves Outcomes Regardless of Prior Surgery

By

Jody A. Charnow

September 17, 2021

As first-line therapy for advanced renal cell carcinoma, nivolumab plus cabozantinib prolongs progression-free survival compared with sunitinib in patients with and without a prior nephrectomy.

Protein expression markers predict disease-specific survival (DSS) in clear cell renal cell carcinom

AUA2021 Virtual Experience

RCC Subtype Affects Post-Nephrectomy Survival Rates

By

Jody A. Charnow

September 13, 2021

Five-year survival rates following nephrectomy for renal cell carcinoma are higher among patients with favorable vs unfavorable histology.

AUA2021 Virtual Experience

Lower Post-Nephrectomy Kidney Function May Up ESKD Risk

By

Jody A. Charnow

September 12, 2021

New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators.

AUA2021 Virtual Experience

Study: Chest Imaging After RCC Surgery Not Warranted

By

Jody A. Charnow

September 11, 2021

Investigators concluded that there is minimal to no clinical value in surveillance for pulmonary recurrence after T1a RCC resection.

Kidney Cancer

Welireg Approved for Cancers Associated With Von Hippel-Lindau Disease

By

Steve Duffy

August 17, 2021

The approval was based on data from an open-label phase 2 study which evaluated the efficacy and safety of Welireg in patients with von Hippel-Lindau-associated renal cell carcinoma and other VHL-associated tumors.